Severe Pulmonary Coccidioidomycosis Treated With Systemic Corticosteroids in an Adolescent Child.

IF 0.5 Q4 PEDIATRICS
Case Reports in Pediatrics Pub Date : 2026-06-19 eCollection Date: 2026-01-01 DOI:10.1155/crpe/6010113
Rod Shinozaki, Paul Krogstad, Kristina Adachi, Yonca Bulut
{"title":"Severe Pulmonary Coccidioidomycosis Treated With Systemic Corticosteroids in an Adolescent Child.","authors":"Rod Shinozaki, Paul Krogstad, Kristina Adachi, Yonca Bulut","doi":"10.1155/crpe/6010113","DOIUrl":null,"url":null,"abstract":"<p><p>Coccidioidomycosis (CM) is an emerging public health challenge due to an increasing number of cases in the U.S. Diagnosis may be challenging because of its nonspecific presentation, which may lead to treatment delays. In addition, the optimal management of severe pulmonary CM remains unclear. We present the case of an 18-year-old immunocompromised renal transplant recipient with a history of systemic lupus erythematosus who developed acute respiratory distress syndrome (ARDS) secondary to severe pulmonary CM. Following initiation of systemic corticosteroids treatment with standard-of-care antifungals, she demonstrated improved clinical response. Severe pulmonary CM may lead to a significant multiorgan inflammatory response in this infection. Our case explores corticosteroid treatment to downregulate this pathophysiologic process and help facilitate clinical resolution of the critical respiratory symptoms and limit morbidity associated with this infection.</p>","PeriodicalId":9623,"journal":{"name":"Case Reports in Pediatrics","volume":"2026 ","pages":"6010113"},"PeriodicalIF":0.5000,"publicationDate":"2026-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13280571/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Pediatrics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/crpe/6010113","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

Abstract

Coccidioidomycosis (CM) is an emerging public health challenge due to an increasing number of cases in the U.S. Diagnosis may be challenging because of its nonspecific presentation, which may lead to treatment delays. In addition, the optimal management of severe pulmonary CM remains unclear. We present the case of an 18-year-old immunocompromised renal transplant recipient with a history of systemic lupus erythematosus who developed acute respiratory distress syndrome (ARDS) secondary to severe pulmonary CM. Following initiation of systemic corticosteroids treatment with standard-of-care antifungals, she demonstrated improved clinical response. Severe pulmonary CM may lead to a significant multiorgan inflammatory response in this infection. Our case explores corticosteroid treatment to downregulate this pathophysiologic process and help facilitate clinical resolution of the critical respiratory symptoms and limit morbidity associated with this infection.

系统性皮质类固醇治疗青少年儿童严重肺球虫菌病。
球孢子菌病(CM)是一个新兴的公共卫生挑战,由于越来越多的病例在美国,诊断可能具有挑战性,因为它的非特异性表现,这可能导致治疗延误。此外,严重肺CM的最佳治疗方法尚不清楚。我们提出的情况下,18岁的免疫功能低下的肾移植受体与历史的系统性红斑狼疮谁发展急性呼吸窘迫综合征(ARDS)继发于严重的肺CM。在开始用标准抗真菌药物进行全身皮质类固醇治疗后,她表现出改善的临床反应。在这种感染中,严重的肺CM可能导致显著的多器官炎症反应。本病例探讨皮质类固醇治疗下调这一病理生理过程,有助于促进严重呼吸道症状的临床解决,并限制与这种感染相关的发病率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
11.10%
发文量
48
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书